Capmatinib hydrochloride

Drug ingredient

CAS 1865733-40-9

This chemical is an active pharmaceutical ingredient used in FDA-regulated drugs.

Molecular structure of 1865733-40-9
2 HCl · 1 H₂O
US productionNot reported
Top sourceNo public record

This chemical is not on EPA’s Toxic Substances Control Act inventory, the list behind EPA’s production survey.

Why supply is unknown

Where It Comes From

EPA and Census publish no US supply data for this chemical.

4 FDA-registered drug labelers
Lianhe Chemical Technology Co.,Ltd.
Novartis Pharma Produktions GmbH
Novartis Pharmaceuticals Corporation
Sterling Pharma Solutions Limited

Why It Matters

Sectors
Health
Downstream Uses

Appears in 1 drug and cosmetic product listings (FDA).

  • •Tabrecta
FDA Shortage Status
No FDA shortage records

Vendor Pricing

$150.00/gCombi-Blocks, Inc.
CountryUnited States
Pack$150.00 / 1 g
Purity95%
Vendors15 available

Prices reflect listed pack sizes. Small research packs run far above bulk rates.

Chemical Identity

CAS1865733-40-9
PubChem CID122201352
DTXSIDDTXSID401027869
FormulaC23H21Cl2FN6O2
Mol. Weight503.4 g/mol
SMILESCNC(=O)C1=C(C=C(C=C1)C2=NN3C(=CN=C3N=C2)CC4=CC5=C(C=C4)N=CC=C5)F.O.Cl.Cl

Data Sources

Brief citations

Capmatinib hydrochloride (CAS 1865733-40-9) https://chemicalindependence.com/chemical/1865733-40-9/ PubChem: 122201352. Retrieved 2026-04-07. https://pubchem.ncbi.nlm.nih.gov/compound/122201352 FDA National Drug Code directory: CAS 1865733-40-9. Retrieved 2026-04-25. https://open.fda.gov/data/ndc/ FDA National Drug Code directory: bulk match. Retrieved 2026-04-07. https://open.fda.gov/data/ndc/